Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway

Ethyl ferulate, a lipophilic phenylpropanoid, prevents diabetes‐associated renal injury in rats by amelioration of hyperglycemia‐induced oxidative stress via activation of nuclear factor erythroid 2‐related factor 2

(2021) Aakruti Arun Kaikini et al.   JOURNAL OF FOOD BIOCHEMISTRY

Ethyl ferulate protects against lipopolysaccharide-induced acute lung injury by activating AMPK/Nrf2 signaling pathway

(2021) Ya-xian Wu et al.   ACTA PHARMACOLOGICA SINICA

Oral administration of ferulic acid or ethyl ferulate attenuates retinal damage in sodium iodate-induced retinal degeneration mice

(2020) Masayuki Kohno et al.   Scientific Reports

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo

(2020) Xueyin Zu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Functional crosstalk between mTORC1/p70S6K pathway and heterochromatin organization in stress-induced senescence of MSCs

(2020) Hailong Liu et al.   Stem Cell Research & Therapy

Ethyl ferulate/β-cyclodextrin inclusion complex inhibits edema formation

(2020) Francisco Valmor Macedo Cunha et al.   Materials Science & Engineering C-Materials for Biological Applications

Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade

(2020) Jianjun Yang et al.   Frontiers in Oncology

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy

(2019) Tian Tian et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Systematic review and technological prospection: ethyl ferulate, a phenylpropanoid with antioxidant and neuroprotective actions

(2019) Francisco Valmor Macedo Cunha et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Akt in cancer: Mediator and more

(2019) Sundaramoorthy Revathidevi et al.   SEMINARS IN CANCER BIOLOGY

Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models

(2019) Okada et al.   Cells

Esophageal carcinoma: Towards targeted therapies

(2019) Ali Fatehi Hassanabad et al.   CELLULAR ONCOLOGY

Esophageal cancer: Risk factors, genetic association, and treatment

(2018) Fang-Liang Huang et al.   Asian Journal of Surgery

Epidemiology of Esophageal Squamous Cell Carcinoma

(2018) Christian C. Abnet et al.   GASTROENTEROLOGY

mTOR Cross-Talk in Cancer and Potential for Combination Therapy

(2018) Fabiana Conciatori et al.   Cancers

Lessons Learned from Two Decades of Anticancer Drugs

(2017) Zhichao Liu et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Prognostic Significance of Periostin and Mammalian Target of Rapamycin (mTOR) in Locally Advanced Esophageal Squamous Cell Carcinoma

(2017) Qi Jiang et al.   MEDICAL SCIENCE MONITOR

p70 S6 Kinase and Tau in Alzheimer's Disease

(2017) Jin-Jing Pei et al.   JOURNAL OF ALZHEIMERS DISEASE

Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis

(2016) Shuangjiang Li et al.   BMC CANCER

mTORC1 and mTORC2 in cancer and the tumor microenvironment

(2016) L C Kim et al.   ONCOGENE

mTOR coordinates protein synthesis, mitochondrial activity and proliferation

(2015) Masahiro Morita et al.   CELL CYCLE

The S6K protein family in health and disease

(2015) Mariana R. Tavares et al.   LIFE SCIENCES

mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy

(2015) Marzia Perluigi et al.   NEUROBIOLOGY OF DISEASE

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

(2014) M. Hidalgo et al.   Cancer Discovery

Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice

(2013) Toshio Nishikawa et al.   CANCER BIOLOGY & THERAPY

The quest to overcome resistance to EGFR-targeted therapies in cancer

(2013) Curtis R Chong et al.   NATURE MEDICINE

Rapamycin passes the torch: a new generation of mTOR inhibitors

(2011) Don Benjamin et al.   NATURE REVIEWS DRUG DISCOVERY

mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?

(2008) J Boone et al.   JOURNAL OF CLINICAL PATHOLOGY